A citation-based method for searching scientific literature

Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
Times Cited: 8089







List of co-cited articles
93 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
15

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
15

RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
13

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
11

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
11

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
10

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
10

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
8

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
8

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
7

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
7

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
6

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
5

AGREE II: advancing guideline development, reporting and evaluation in health care.
Melissa C Brouwers, Michelle E Kho, George P Browman, Jako S Burgers, Francoise Cluzeau, Gene Feder, Béatrice Fervers, Ian D Graham, Jeremy Grimshaw, Steven E Hanna,[...]. CMAJ 2010
5

What is "quality of evidence" and why is it important to clinicians?
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Gunn E Vist, Yngve Falck-Ytter, Holger J Schünemann. BMJ 2008
5

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
5

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
5

Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
5

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
4

Estimating the mean and variance from the median, range, and the size of a sample.
Stela Pudar Hozo, Benjamin Djulbegovic, Iztok Hozo. BMC Med Res Methodol 2005
4

Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
Miranda Cumpston, Tianjing Li, Matthew J Page, Jacqueline Chandler, Vivian A Welch, Julian Pt Higgins, James Thomas. Cochrane Database Syst Rev 2019
919
4


Guidelines International Network: toward international standards for clinical practice guidelines.
Amir Qaseem, Frode Forland, Fergus Macbeth, Günter Ollenschläger, Sue Phillips, Philip van der Wees. Ann Intern Med 2012
424
4

Practical methods for incorporating summary time-to-event data into meta-analysis.
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, Sarah Burdett, Matthew R Sydes. Trials 2007
3

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
3

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
3

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
Andrea C Tricco, Erin Lillie, Wasifa Zarin, Kelly K O'Brien, Heather Colquhoun, Danielle Levac, David Moher, Micah D J Peters, Tanya Horsley, Laura Weeks,[...]. Ann Intern Med 2018
3

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
3

Guideline panels should not GRADE good practice statements.
Gordon H Guyatt, Holger J Schünemann, Benjamin Djulbegovic, Elie A Akl. J Clin Epidemiol 2015
95
3

GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
Pablo Alonso-Coello, Holger J Schünemann, Jenny Moberg, Romina Brignardello-Petersen, Elie A Akl, Marina Davoli, Shaun Treweek, Reem A Mustafa, Gabriel Rada, Sarah Rosenbaum,[...]. BMJ 2016
349
3

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).
Gordon H Guyatt, Andrew D Oxman, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Victor Montori, Elie A Akl, Ben Djulbegovic, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2011
3


GRADE guidelines: 7. Rating the quality of evidence--inconsistency.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Paul Glasziou, Roman Jaeschke, Elie A Akl,[...]. J Clin Epidemiol 2011
2

The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence.
Zachary Munn, Sandeep Moola, Dagmara Riitano, Karolina Lisy. Int J Health Policy Manag 2014
397
2

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.
Jonathan A C Sterne, Alex J Sutton, John P A Ioannidis, Norma Terrin, David R Jones, Joseph Lau, James Carpenter, Gerta Rücker, Roger M Harbord, Christopher H Schmid,[...]. BMJ 2011
2

An evidence-based prehospital guideline for external hemorrhage control: American College of Surgeons Committee on Trauma.
Eileen M Bulger, David Snyder, Karen Schoelles, Cathy Gotschall, Drew Dawson, Eddy Lang, Nels D Sanddal, Frank K Butler, Mary Fallat, Peter Taillac,[...]. Prehosp Emerg Care 2014
102
2

Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions.
J L Brozek, E A Akl, P Alonso-Coello, D Lang, R Jaeschke, J W Williams, B Phillips, M Lelgemann, A Lethaby, J Bousquet,[...]. Allergy 2009
328
2

Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics.
Phillip L Lieberman, Ilisten Jones, Richa Rajwanshi, Karin Rosén, Dale T Umetsu. J Allergy Clin Immunol 2017
29
6

Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis.
Penny Whiting, Maiwenn Al, Marie Westwood, Isaac Corro Ramos, Steve Ryder, Nigel Armstrong, Kate Misso, Janine Ross, Johan Severens, Jos Kleijnen. Health Technol Assess 2015
147
2

Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding.
Anne Wikkelsø, Jørn Wetterslev, Ann Merete Møller, Arash Afshari. Cochrane Database Syst Rev 2016
180
2

Visual function and quality of life among patients with glaucoma.
R K Parrish, S J Gedde, I U Scott, W J Feuer, J C Schiffman, C M Mangione, A Montenegro-Piniella. Arch Ophthalmol 1997
282
2


Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, Anurag Garg, Victoria Vickerstaff, Rachael Hunter, Gareth Ambler, Catey Bunce, Richard Wormald, Neil Nathwani,[...]. Lancet 2019
137
2

Going from evidence to recommendations.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Yngve Falck-Ytter, Gunn E Vist, Alessandro Liberati, Holger J Schünemann. BMJ 2008
2

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines.
S H Woolf, R Grol, A Hutchinson, M Eccles, J Grimshaw. BMJ 1999
2

American College of Obstetricians and Gynecologists practice bulletins: an overview.
Suneet P Chauhan, Vincenzo Berghella, Maureen Sanderson, Everett F Magann, John C Morrison. Am J Obstet Gynecol 2006
28
7


A vision statement on guideline development for respiratory disease: the example of COPD.
Holger J Schünemann, Mark Woodhead, Antonio Anzueto, Sonia Buist, William Macnee, Klaus F Rabe, John Heffner. Lancet 2009
56
3



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.